U.S. markets closed

Predictive Oncology Inc. (POAI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1800+0.0300 (+2.61%)
At close: 4:00PM EDT
1.1800 0.00 (0.00%)
After hours: 07:58PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 7/27/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.95
52-Week Change 3-27.22%
S&P500 52-Week Change 335.08%
52 Week High 32.3000
52 Week Low 30.6300
50-Day Moving Average 31.1729
200-Day Moving Average 31.2615

Share Statistics

Avg Vol (3 month) 32.84M
Avg Vol (10 day) 31.78M
Shares Outstanding 565.34M
Implied Shares Outstanding 6N/A
Float 47.82M
% Held by Insiders 17.68%
% Held by Institutions 17.45%
Shares Short (Jul 14, 2021) 41.51M
Short Ratio (Jul 14, 2021) 40.34
Short % of Float (Jul 14, 2021) 42.32%
Short % of Shares Outstanding (Jul 14, 2021) 42.31%
Shares Short (prior month Jun 14, 2021) 42.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 28, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Oct 28, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-1,035.99%

Management Effectiveness

Return on Assets (ttm)-24.77%
Return on Equity (ttm)-109.99%

Income Statement

Revenue (ttm)1.24M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)-5.00%
Gross Profit (ttm)805.08k
EBITDA -11.68M
Net Income Avi to Common (ttm)-25.8M
Diluted EPS (ttm)-1.3040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.3M
Total Cash Per Share (mrq)0.55
Total Debt (mrq)1.29M
Total Debt/Equity (mrq)3.62
Current Ratio (mrq)8.65
Book Value Per Share (mrq)0.73

Cash Flow Statement

Operating Cash Flow (ttm)-12.61M
Levered Free Cash Flow (ttm)-11.16M